Nodular Sclerosis Hodgkin Lymphoma, Intra-Abdominal Lymph Nodes (C81.13)

Name of the Condition

• Common Name: Nodular Sclerosis Hodgkin Lymphoma (Intra-Abdominal Lymph Nodes)
• Medical Terms: Nodular Sclerosis Hodgkin's Disease, NSHL

Summary

Nodular sclerosis Hodgkin lymphoma (NSHL) is a subtype of Hodgkin lymphoma defined by Reed-Sternberg cells and a fibrous nodular pattern in affected lymph nodes. This specific code (C81.13) indicates involvement of intra-abdominal lymph nodes. NSHL is the most common subtype of Hodgkin lymphoma and typically presents with painless lymph node enlargement. It tends to affect young adults and has a favorable prognosis with standard treatment.

Causes

The exact cause of NSHL is not fully understood, but it is believed to result from a combination of genetic and environmental factors. Viral infections, such as Epstein-Barr virus (EBV), may contribute to its development, though not all cases are associated with EBV. Genetic predisposition and immune system interactions are also thought to play a role.

Risk Factors

• Age: Most commonly diagnosed in young adults (15-35 years) and adolescents.
• Gender: Slightly more prevalent in females.
• Family History: Having a first-degree relative with lymphoma may increase risk.
• Epstein-Barr Virus: Prior infection may elevate susceptibility.

Symptoms

• Painless swelling of lymph nodes, often in the abdomen.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintentional weight loss.
• Abdominal discomfort or fullness.

Diagnosis

Diagnosis involves a combination of physical examination, imaging studies (e.g., CT scans), and biopsy of affected lymph nodes. Pathology confirms the presence of Reed-Sternberg cells and the characteristic nodular sclerosis pattern. Staging determines the extent of disease, which guides treatment planning.

Treatment Options

Treatment typically includes chemotherapy, often combined with radiation therapy for localized disease. Standard regimens may involve ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) or similar protocols. Stem cell transplantation may be considered for relapsed or refractory cases.

Prognosis and Follow-Up

NSHL has a favorable prognosis, with high cure rates when treated appropriately. Follow-up includes regular monitoring for recurrence, typically with imaging and clinical assessments. Long-term survivors may require surveillance for late effects of treatment.

Complications

Potential complications include treatment-related toxicities (e.g., cardiopulmonary effects from chemotherapy or radiation), secondary malignancies, and lymphedema. Disease progression or relapse may occur in some cases.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining overall health, avoiding known carcinogens, and prompt evaluation of persistent symptoms may aid early detection. Supportive care, including nutrition and mental health support, is important during treatment.

When to Seek Professional Help

Seek medical attention for persistent abdominal swelling, unexplained weight loss, fever, or night sweats. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use C81.13 for nodular sclerosis Hodgkin lymphoma with documented involvement of intra-abdominal lymph nodes. Ensure documentation specifies the anatomical site to support code assignment. Verify that the diagnosis aligns with pathology findings and clinical presentation.